IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i3p1058-d486777.html
   My bibliography  Save this article

Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project

Author

Listed:
  • Antonio Carmona

    (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Avenida Cataluña 21, 46020 Valencia, Spain)

  • Cintia Muñoz-Quiles

    (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Avenida Cataluña 21, 46020 Valencia, Spain)

  • Anke Stuurman

    (P-95 CVBA, Koning Leopold III laan 1, 3001 Heverlee, Belgium)

  • Alexandre Descamps

    (INSERM CIC 1417, Assistance Publique-Hôpitaux de Paris, Université de Paris, Hôpital Cochin, 75005 Paris, France)

  • Ainara Mira-Iglesias

    (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Avenida Cataluña 21, 46020 Valencia, Spain)

  • Laurence Torcel-Pagnon

    (Sanofi-Pasteur SA (SP), 14 Espace Henry Vallée, 69007 Lyon, France)

  • Javier Díez-Domingo

    (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Avenida Cataluña 21, 46020 Valencia, Spain)

Abstract

The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public–private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to work with public health institutes to set up a joint IVE study platform. The COVID-19 pandemic reached Europe in February 2020 and overlapped with the 2019/2020 influenza season only in the last weeks. However, several elements of the DRIVE study network were impacted. The pandemic specifically affected the study sites’ routines and the subsequent assessment of the 2019/20 influenza season. Moreover, the current social distancing measures and lockdown policies across Europe are expected to also limit the circulation of influenza for the 2020/21 season, and therefore the impact of COVID-19 will be higher than in the season 2019/20. Consequently, DRIVE has planned to adapt its study platform to the COVID-19 challenge, encompassing several COVID-19 particularities in the study procedures, data collection and IVE analysis for the 2020/21 season. DRIVE will study the feasibility of implementing these COVID-19 components and establish the foundations of future COVID-19 vaccine effectiveness studies.

Suggested Citation

  • Antonio Carmona & Cintia Muñoz-Quiles & Anke Stuurman & Alexandre Descamps & Ainara Mira-Iglesias & Laurence Torcel-Pagnon & Javier Díez-Domingo, 2021. "Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project," IJERPH, MDPI, vol. 18(3), pages 1-16, January.
  • Handle: RePEc:gam:jijerp:v:18:y:2021:i:3:p:1058-:d:486777
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/3/1058/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/18/3/1058/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:3:p:1058-:d:486777. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.